COMPANY PROFILE // THE 014 REPORT
Biofrontera Inc.
BFRI (Nasdaq) · BFRIW (Nasdaq)
Assembled from 3 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2026-01-07 and 3 more times (last 24 months).
- Amber8-K Item 4.01 filed: change in the company's certifying accountant (auditor) on 2025-04-18 (last 24 months).
- AmberLEI 984500444S8BE1EF0179 registration status is LAPSED (last update 2024-03-24): the legal-entity record has not been renewed.
- InfoGLEIF: no direct parent reported; reporting exception reason NATURAL_PERSONS.
✓ SEC filings✓ LEI✓ State registrationpossible match✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no website, no lobbying registration on record.
Biofrontera Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in DE, based in Woburn, MA; listed as BFRI (Nasdaq), BFRIW (Nasdaq).[source] It reported revenue of $41.7 million for the fiscal year ended 2025-12-31.[source] It has filed 35 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-13.[source] Its largest institutional holders on 13F filings are Rosalind Advisors, Inc., AIGH Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC (as of 2026-06-30).[source] Seraphix flags 3 items from these records: 8-K Item 4.01 filed; 8-K Item 3.01 filed; LEI 984500444S8BE1EF0179 registration status is LAPSED (last update 2024-03-24).[source]
- red0
- amber3
- info1
- Rosalind Advisors, Inc.$1.2M
- AIGH Capital Management LLC$700K
- RENAISSANCE TECHNOLOGIES LLC$149K
- CITADEL ADVISORS LLC$99K
- JANE STREET GROUP, LLC$88K
- GEODE CAPITAL MANAGEMENT, LLC$73K
- VANGUARD CAPITAL MANAGEMENT LLC$68K
- VANGUARD FIDUCIARY TRUST CO$58K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Jones George Patrick · Chief Commercial Officer (Officer) · latest Form 4 2026-03-06 · filing · LinkedIn search
- Leffler Eugene Frederick · Chief Financial Officer (Officer) · latest Form 4 2026-03-06 · filing · LinkedIn search
- Luebbert Hermann · CEO & Chairman (Director,Officer) · latest Form 4 2026-03-06 · filing · LinkedIn search
- BORER JOHN J III · Director · latest Form 4 2026-03-06 · filing · LinkedIn search
- Biofrontera AG · Director,10% owner · latest Form 4 2025-09-18 · filing · LinkedIn search
- Hoffman Beth J. · Director · latest Form 4 2026-03-06 · filing · LinkedIn search
- Lanckriet Heikki · Director · latest Form 4 2026-03-06 · filing · LinkedIn search
- Weber Kevin Daniel · Director · latest Form 4 2026-03-06 · filing · LinkedIn search
- de la Huerta Martinez Maria del Pilar · Director,10% owner · latest Form 3 2025-09-25 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- McGuireWoods LLP · Exhibit 5.1 legal opinion, S-1 filed 2025-12-05
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001858685 | source |
| LEI | 984500444S8BE1EF0179 | source |
| EIN | 47-3765675 | source |
| NY DOS ID | 5156579 | record |
| Connecticut business ID | 1232780 | record |
| Business address (SEC) | 120 PRESIDENTIAL WAY,, WOBURN, MA, 01801 | source |
Does not exist in the records we hold: UEI, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2024-03-24 · in -971 days · LEI next renewal (984500444S8BE1EF0179)
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-30 filing 25-NSE · SEC EDGAR
- 2026-09-14 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-22 filing S-8 · SEC EDGAR
- 2026-07-22 filing 10-K/A · SEC EDGAR
- 2026-06-17 filing 8-K items 5.07 · SEC EDGAR
- 2026-05-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-14 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-30 filing Proxy statement · SEC EDGAR
- 2026-03-19 filing Annual report (10-K) · SEC EDGAR
- 2026-03-19 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-03-09 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-02-26 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-02-09 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-01-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-01-07 filing 8-K items 3.01 · SEC EDGAR
- 2025-12-19 filing EFFECT · SEC EDGAR
- 2025-12-17 filing CORRESP · SEC EDGAR
- 2025-12-05 filing Registration (S-1) · SEC EDGAR
- 2025-11-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-10 filing 8-K items 8.01 · SEC EDGAR
- 2025-11-07 filing 8-K items 1.01,2.01,7.01,9.01 · SEC EDGAR
- 2025-10-24 filing 8-K items 1.01,2.01,3.02,8.01,9.01 · SEC EDGAR
- 2025-10-23 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-09-25 insider First Form 3/4/5 on record for de la Huerta Martinez Maria del Pilar (Director,10% owner) · SEC Forms 3/4/5
- 2025-09-19 filing 8-K items 5.07 · SEC EDGAR
170 earlier entries
- 2025-09-19 filing SCHEDULE 13D/A
- 2025-09-16 insider First Form 3/4/5 on record for Jones George Patrick (Chief Commercial Officer)
- 2025-09-16 insider First Form 3/4/5 on record for Leffler Eugene Frederick (Chief Financial Officer)
- 2025-09-16 insider First Form 3/4/5 on record for Luebbert Hermann (CEO & Chairman)
- 2025-09-16 insider First Form 3/4/5 on record for BORER JOHN J III (Director)
- 2025-09-16 insider First Form 3/4/5 on record for Hoffman Beth J. (Director)
- 2025-09-16 insider First Form 3/4/5 on record for Lanckriet Heikki (Director)
- 2025-09-16 insider First Form 3/4/5 on record for Weber Kevin Daniel (Director)
- 2025-08-19 filing EFFECT
- 2025-08-15 filing CORRESP
- 2025-08-13 filing S-1/A
- 2025-08-13 filing 8-K items 2.02,9.01
- 2025-08-13 filing Quarterly report (10-Q)
- 2025-08-11 officer change 8-K items 5.02,7.01,9.01
- 2025-08-05 filing Proxy statement
- 2025-07-25 filing PRE 14A
- 2025-07-25 filing SCHEDULE 13D/A
- 2025-07-16 filing Registration (S-1)
- 2025-07-16 filing 8-K/A items 9.01
- 2025-07-11 filing D
- 2025-07-09 insider First Form 3/4/5 on record for Biofrontera AG (Director,10% owner)
- 2025-07-01 filing 8-K items 1.01,3.02,3.03,5.03,9.01
- 2025-06-30 filing 8-K items 7.01,9.01
- 2025-06-18 filing 8-K items 5.07
- 2025-06-11 filing 8-K items 8.01,9.01
- 2025-06-03 filing 8-K items 8.01,9.01
- 2025-06-03 filing DEFR14A
- 2025-05-23 filing 8-K items 3.01
- 2025-05-15 filing 8-K items 2.02,9.01
- 2025-05-15 filing Quarterly report (10-Q)
- 2025-05-14 filing 8-K items 3.01
- 2025-04-30 filing Proxy statement
- 2025-04-18 filing 8-K items 4.01,9.01
- 2025-04-18 filing PRE 14A
- 2025-03-21 filing 8-K items 2.02,9.01
- 2025-03-20 filing Annual report (10-K)
- 2025-01-28 filing EFFECT
- 2025-01-24 filing CORRESP
- 2025-01-22 filing UPLOAD
- 2025-01-17 filing Registration (S-1)
- 2024-12-20 filing SCHEDULE 13D/A
- 2024-12-05 filing D
- 2024-11-27 filing 8-K items 1.01,2.03,3.01,9.01
- 2024-11-22 filing 8-K items 7.01,9.01
- 2024-11-14 filing Quarterly report (10-Q)
- 2024-11-13 filing 8-K items 2.02,9.01
- 2024-11-13 filing S-8
- 2024-10-31 filing 8-K items 7.01,9.01
- 2024-10-07 filing 8-K items 7.01,9.01
- 2024-08-14 filing 8-K items 2.02,9.01
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-06-24 filing 8-K items 7.01,9.01
- 2024-06-14 officer change 8-K items 5.02,5.07,9.01
- 2024-05-22 filing 8-K items 8.01
- 2024-05-15 filing 8-K items 2.02,9.01
- 2024-05-15 filing Quarterly report (10-Q)
- 2024-05-09 filing EFFECT
- 2024-05-08 filing CORRESP
- 2024-05-08 filing UPLOAD
- 2024-05-03 filing 8-K items 7.01,8.01,9.01
- 2024-05-03 filing Registration (S-1)
- 2024-04-30 filing 8-K items 5.03,9.01
- 2024-04-30 filing DEFR14A
- 2024-04-25 filing 8-K items 5.07
- 2024-04-22 filing EFFECT
- 2024-04-22 filing CORRESP
- 2024-04-17 filing Proxy statement
- 2024-04-03 filing 8-K/A items 8.01
- 2024-03-26 filing 8-K items 5.08,8.01,9.01
- 2024-03-21 filing Proxy statement
- 2024-03-20 filing S-1/A
- 2024-03-18 filing UPLOAD
- 2024-03-15 filing 8-K items 2.02,9.01
- 2024-03-15 filing Annual report (10-K)
- 2024-03-11 filing Registration (S-1)
- 2024-03-08 filing PRE 14A
- 2024-03-05 filing D
- 2024-02-23 filing 8-K items 1.01,3.02,3.03,5.03,7.01,8.01,9.01
- 2024-02-20 filing 8-K items 1.01,7.01,8.01,9.01
- 2024-02-20 filing RW
- 2024-02-13 filing 8-K items 8.01
- 2024-02-05 filing 8-K items 7.01,9.01
- 2024-02-02 filing 8-K items 1.01,8.01,9.01
- 2024-01-29 filing S-1/A
- 2024-01-25 filing 8-K items 3.01
- 2024-01-17 filing Registration (S-1)
- 2024-01-11 filing 8-K items 2.02,9.01
- 2024-01-09 filing 8-K/A items 1.02
- 2024-01-03 filing 8-K items 1.01,7.01,9.01
- 2023-12-28 filing 8-K items 1.01,1.02,2.03
- 2023-12-27 filing 8-K items 5.07
- 2023-12-15 filing 8-K items 1.01,9.01
- 2023-11-29 filing 8-K items 3.01
- 2023-11-17 filing Proxy statement
- 2023-11-09 filing Quarterly report (10-Q)
- 2023-11-09 filing 8-K items 2.02,9.01
- 2023-11-02 filing 8-K items 1.01,3.03,7.01,9.01
- 2023-11-01 filing 424B4
- 2023-10-30 filing EFFECT
- 2023-10-27 filing CORRESP
- 2023-10-27 filing S-1/A
- 2023-10-16 filing S-1/A
- 2023-10-13 filing CORRESP
- 2023-10-13 filing 8-K items 1.01,9.01
- 2023-10-11 filing UPLOAD
- 2023-10-10 filing 8-K items 7.01,9.01
- 2023-10-05 filing Registration (S-1)
- 2023-10-04 filing 8-K items 2.02,9.01
- 2023-10-03 filing 8-K items 8.01,9.01
- 2023-08-11 filing 8-K items 2.02,9.01
- 2023-08-11 filing Quarterly report (10-Q)
- 2023-07-13 filing 8-K items 2.02,9.01
- 2023-07-12 officer change 8-K items 5.02,7.01,9.01
- 2023-07-03 filing 8-K items 3.03,5.03,7.01,9.01
- 2023-06-20 filing 8-K items 4.01
- 2023-06-02 filing 8-K items 4.01,9.01
- 2023-06-01 filing 8-K items 7.01,9.01
- 2023-05-30 filing 8-K items 7.01,9.01
- 2023-05-26 officer change 8-K items 3.01,5.02,5.07,9.01
- 2023-05-12 filing Quarterly report (10-Q)
- 2023-05-12 officer change 8-K items 2.02,5.02,7.01,9.01
- 2023-04-28 filing 8-A12B/A
- 2023-04-28 filing 8-K items 1.01,3.03,9.01
- 2023-04-21 filing Proxy statement
- 2023-04-17 filing 8-K items 1.01
- 2023-04-11 filing PRE 14A
- 2023-03-13 filing Annual report (10-K)
- 2023-03-08 filing 8-K items 2.02,9.01
- 2023-03-02 filing 8-K items 3.01
- 2023-01-09 filing 8-K items 2.02,9.01
- 2022-12-16 officer change 8-K items 5.02,5.07,9.01
- 2022-12-08 filing DEFA14A
- 2022-11-29 filing DEFA14A
- 2022-11-21 filing DEFA14A
- 2022-11-15 filing 424B3
- 2022-11-15 filing 424B3
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-14 filing 8-K items 2.02,9.01
- 2022-11-14 filing DEFR14A
- 2022-11-09 filing 8-K items 7.01,8.01,9.01
- 2022-11-08 filing Proxy statement
- 2022-11-07 filing EFFECT
- 2022-11-04 filing D
- 2022-11-03 filing CORRESP
- 2022-11-03 filing Registration (S-1)
- 2022-10-31 filing 8-K items 1.01,3.02,7.01,9.01
- 2022-10-24 officer change 8-K items 5.02,7.01,9.01
- 2022-10-14 filing 8-K items 1.01,3.03,5.03,8.01,9.01
- 2022-10-14 filing 8-A12B
- 2022-10-05 filing 8-K items 2.02,9.01
- 2022-09-19 filing SC 13D/A
- 2022-08-30 filing UPLOAD
- 2022-08-29 filing DRS
- 2022-08-26 filing DRSLTR
- 2022-08-25 filing SC 13D
- 2022-08-12 filing 8-K items 2.02,9.01
- 2022-08-12 filing Quarterly report (10-Q)
- 2022-08-11 filing D
- 2022-07-28 filing 8-K items 1.01,3.02,3.03,8.01,9.01
- 2022-07-12 filing 8-K items 2.02,9.01
- 2022-06-13 filing EFFECT
- 2022-06-10 filing POS AM
- 2022-06-09 filing EFFECT
- 2022-06-09 filing 424B3
- 2022-06-07 filing CORRESP
- 2022-06-07 filing Registration (S-1)
- 2022-06-07 filing S-8
- 2022-06-01 filing UPLOAD
- 2022-05-27 filing DRSLTR
- 2022-05-27 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-13 (within 30 days) 10-Q filed
- 2026-11-13 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-30 (within 30 days) 25-NSE filed
- 2026-09-14 (older) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-08-13 (older) 10-Q filed
- 2026-08-13 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-22 (older) S-8 filed
- 2026-07-22 (older) 10-K/A filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:BFRI The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
5 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1858685 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | BFRI / Nasdaq, Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 984500444S8BE1EF0179 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 984500444S8BE1EF0179) | GLEIF |
| EIN | 473765675 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001858685 | SEC EDGAR / IRS |
| CUSIP | 09077D209 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001858685 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $41,705,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 15:04 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$10,536,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 15:04 UTC | Report an error |
| Total assets (at 2025-12-31) | $28,564,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 15:04 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $10,480,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 15:04 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $6,392,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 15:04 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
| State of incorporation | DE | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
| Business address | 120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801 | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
| Exchanges | Nasdaq, Nasdaq | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 15:04 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$13,361,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 15:04 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $2,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 15:04 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,572,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 15:04 UTC | Report an error |
| Form D total offering amount (D filed 2025-07-11) | $11,000,000 | 2025-07-11 | D | as filed | 2026-11-20 15:04 UTC | Report an error |
| Form D total amount sold (D filed 2025-07-11) | $11,000,000 | 2025-07-11 | D | as filed | 2026-11-20 15:04 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2025-07-11 | D | as filed | 2026-11-20 15:04 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-07-11 | D | as filed | 2026-11-20 15:04 UTC | Report an error |
| Form D date of first sale | 2025-06-27 | 2025-07-11 | D | as filed | 2026-11-20 15:04 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001493152-26-051781
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $9,070,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001493152-26-051781 | 2026-11-20 15:04 UTC | Report an error |
| Net income (loss) | -$6,423,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001493152-26-051781 | 2026-11-20 15:04 UTC | Report an error |
| Cash and cash equivalents | $3,218,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001493152-26-051781 | 2026-11-20 15:04 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-13 Filing 10-Q filed
- 2026-11-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-30 Filing 25-NSE filed
- 2026-09-14 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-08-13 Filing 10-Q filed
- 2026-08-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-22 Filing S-8 filed
- 2026-07-22 Filing 10-K/A filed
- 2026-06-17 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-14 Filing 10-Q filed
- 2026-05-14 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-30 Filing DEF 14A filed
- 2026-03-19 Filing 10-K filed
- 2026-03-19 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-03-09 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-02-26 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-02-09 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-01-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-07 Filing 8-K filed: Item 3.01 delisting notice
- 2025-12-19 Filing EFFECT filed
- 2025-12-17 Filing CORRESP filed
- 2025-12-05 Filing S-1 filed
- 2025-11-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-11-12 Filing 10-Q filed
- 2025-11-10 Filing 8-K filed: Item 8.01 other event
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | $1,206,088 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 2 | AIGH Capital Management LLC | $699,585 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $148,921 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 4 | CITADEL ADVISORS LLC | $99,222 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 5 | JANE STREET GROUP, LLC | $87,932 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $72,513 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $67,525 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 8 | VANGUARD FIDUCIARY TRUST CO | $58,365 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 9 | XTX Topco Ltd | $49,066 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
| 10 | NORTHERN TRUST CORP | $29,817 | 2026-06-30 | SEC 13F filing | 2026-11-20 15:04 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- BIOFRONTERA INC. · LEI 984500444S8BE1EF0179 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
5 state and city records carry this company's exact name, from 4 sources. Possible matches only.
State licences (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchBIOFRONTERA INC. · exact legal name · sx:elic:ctcred:2546696 Compare
- possible matchBIOFRONTERA INC. · exact legal name · sx:elic:ctcred:1388578 Compare
Connecticut business registrations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchBIOFRONTERA INC. · exact legal name · sx:ctsos:1232780 Compare
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchBiofrontera Inc. · exact legal name · sx:ctgov:h8c149b80cdda56b5 Compare
New York corporations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchBIOFRONTERA INC. · exact legal name · sx:nydos:5156579 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1858685.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001858685. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.